Reduction of PaCO2 by high-flow nasal cannula in acute hypercapnic respiratory failure patients receiving conventional oxygen therapy.

Hyun Woo Lee Sun Mi Choi Jinwoo Lee Young Sik Park Chang Hoon Lee Chul Gyu Yoo Young Whan Kim Sung Koo Han Sang-Min Lee

Published in: Acute and critical care (2019)

Physiological parameters can improve after the use of an HFNC in patients with acute hypercapnic respiratory failure given low-flow O2 therapy via a facial mask. Further studies are needed to identify which hypercapnic patients might benefit from an HFNC.

Keyphrases

respiratory failure
extracorporeal membrane oxygenation
mechanical ventilation
ejection fraction
acute respiratory distress syndrome
newly diagnosed
prognostic factors
intensive care unit
stem cells
mesenchymal stem cells
patient reported outcomes
hepatitis b virus
soft tissue